TEXAS ONCOLOGY–MCALLEN TO HOST PRESS CONFERENCE FOR OCT. 25 FUNDRAISER

Breaking News
2162

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

7th Annual Walk, Run, and Ride Promotes Breast Cancer Awareness and Rallies Survivors

What:              Texas Oncology–McAllen and City Commissioner Veronica Vela Whitacre will host a press conference on Tuesday, Oct. 14 to discuss the upcoming Walk, Run, and Ride promoting breast cancer awareness.

                        The 7th edition of the event begins at 8 a.m., on Saturday, Oct. 25 at Texas Oncology–McAllen, located at 1901South Second Street. Registration for the 5k run; 2.5 or 4.5 mile walk; or 20, 40, or 60 mile bicycle rally is now open. Proceeds from the event benefit the Texas Oncology Foundation, Comfort House, Food Bank of the RGV, Infinite Love, and Aurora House. For more information or to register, visit TXOWalkRunRide.com.

- Advertisement -

When:              Tuesday, Oct. 14 –10 a.m.

Where:            Texas Oncology–McAllen, 1901 South Second Street, McAllen, Texas, 78503 

Who:               Alvaro Restrepo, M.D., medical oncologist at Texas Oncology–McAllen, and event chairman Veronica Vela Whitacre, McAllen city commissioner. Other Walk, Run, and Ride participants

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Hispanics Must Promote Longer, Healthier Lives
Next article
Video: How do you get Ebola?

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -